论文部分内容阅读
近日,休斯敦卫理公会研究所(Houston Methodist Research Institute)的研究人员通过研究表示,一种实验性药物或可促进小鼠脂肪和体质量下降。相关研究在圣地亚哥举办的第97届美国内分泌学会年会(ENDO2015)上发表。这种药物名为GC-1,其可以加速机体脂肪细胞代谢燃烧脂肪。研究者Kevin Phillips博士表示GC-1可以明显增加小鼠机体的代谢率,从本质上将有害的白色脂肪(white fat)转化成为有益的褐色脂肪(brown fat),白色脂肪往往那个可以储存过多热量,而且其和糖尿病及代谢性疾病的发
Researchers at the Houston Methodist Research Institute recently said that an experimental drug may promote fat and body weight loss in mice. Relevant studies were presented at the 97th Annual Meeting of the American Society of Endocrinology (ENDO2015) in San Diego. The drug, called GC-1, accelerates fat metabolism in the body’s fat cells. Researcher Kevin Phillips, Ph.D., said GC-1 significantly increases the body’s metabolic rate in mice, essentially converting harmful white fat to beneficial brown fat, and white fat is often the one that can be stored too much Heat, but also with diabetes and metabolic diseases hair